mHealth | ATC innovation Lab
Back to Top
Subscribe to RSS - mHealth


m-RESIST: support tools for schizophrenia with mobile technologies

m-RESIST project has published today its first newsletter. In this first issue the readers will have the opportunity to be informed on the project's developments, news and progress achieved throughout the first year of the project.

International 360° Summit on eHealth, Budapest, Hungary, 14-16 June 2016

eHealth 360° Summit 2016, organized by the European Alliance for Innovation (EAI) under the patronage of European Commission, will be held during 14-16 June 2016 in Budapest, Hungary. The Summit is a unique event bringing a 360 degree perspective on mobile and electronic health.


m-RESIST Project (Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia), a project co-funded by the EU under H2020-PHC-26-2014 Programme aims to develop a therapeutic program that draws on the support of mobile devices to actively involve patients with treatment-resistant schizophrenia, to make them capable of self-managing their own illness, as well as to support th

m-RESIST: First European mHealth project for patients with treatment-resistant schizophrenia

m-RESIST is an innovative project aimed to manage schizophrenia in patients resistant to treatment and to help their carers.
The objective is also to further develop knowledge related to the illness by studying predictive models.